Connect Biopharma Holdings Stock Price on October 21, 2024

CNTB Stock  USD 1.00  0.01  0.99%   
If you're considering investing in Connect Stock, it is important to understand the factors that can impact its price. As of today, the current price of Connect Biopharma stands at 1.00, as last reported on the 25th of December, with the highest price reaching 1.02 and the lowest price hitting 0.97 during the day. Connect Biopharma secures Sharpe Ratio (or Efficiency) of -0.0806, which signifies that the company had a -0.0806% return per unit of risk over the last 3 months. Connect Biopharma Holdings exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Connect Biopharma's Mean Deviation of 3.92, risk adjusted performance of (0.02), and Standard Deviation of 5.1 to double-check the risk estimate we provide.
  
At present, Connect Biopharma's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 10.1 K, whereas Common Stock Shares Outstanding is forecasted to decline to about 43.5 M. . At present, Connect Biopharma's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price Earnings Ratio is forecasted to decline to (1.15). Connect Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0806

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCNTB

Estimated Market Risk

 5.02
  actual daily
44
56% of assets are more volatile

Expected Return

 -0.4
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.08
  actual daily
0
Most of other assets perform better
Based on monthly moving average Connect Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Connect Biopharma by adding Connect Biopharma to a well-diversified portfolio.
Price Book
0.5038
Enterprise Value Ebitda
0.1857
Price Sales
2.3081
Shares Float
14.8 M
Wall Street Target Price
7

Related Headline

Instil Bio Headline on 21st of October 2024

Filed transaction by Instil Bio Director. Grant, award or other acquisition pursuant to Rule 16b-3

Connect Biopharma Valuation on October 21, 2024

It is possible to determine the worth of Connect Biopharma on a given historical date. On October 21, 2024 Connect was worth 1.2 at the beginning of the trading date compared to the closed value of 1.21. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Connect Biopharma stock. Still, in general, we apply an absolute valuation method to find Connect Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Connect Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Connect Biopharma's related companies.
 Open High Low Close Volume
  1.25    1.25    1.25    1.25    1,521  
10/21/2024
  1.20    1.23    1.14    1.21    33,281  
  1.21    1.22    1.18    1.22    15,995  
Backtest Connect Biopharma  |  Connect Biopharma History  |  Connect Biopharma Valuation   PreviousNext  
Open Value
1.2
1.21
Closing Value
16.26
Upside

Connect Biopharma Trading Date Momentum on October 21, 2024

On October 22 2024 Connect Biopharma Holdings was traded for  1.22  at the closing time. The top price for the day was 1.22  and the lowest listed price was  1.18 . The trading volume for the day was 16 K. The trading history from October 22, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 0.83% . The overall trading delta against the current closing price is 3.31% .

Connect Biopharma Fundamentals Correlations and Trends

By evaluating Connect Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Connect Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Connect financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Connect Biopharma Stock history

Connect Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Connect is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Connect Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Connect Biopharma stock prices may prove useful in developing a viable investing in Connect Biopharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding55.1 M43.5 M
Net Loss-1.2 B-1.1 B

Connect Biopharma Quarterly Net Working Capital

96.71 Million

Connect Biopharma Stock Technical Analysis

Connect Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Connect Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Connect Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Connect Biopharma Period Price Range

Low
December 25, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Connect Biopharma Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Connect Biopharma December 25, 2024 Market Strength

Market strength indicators help investors to evaluate how Connect Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Connect Biopharma shares will generate the highest return on investment. By undertsting and applying Connect Biopharma stock market strength indicators, traders can identify Connect Biopharma Holdings entry and exit signals to maximize returns

Connect Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Connect Biopharma's price direction in advance. Along with the technical and fundamental analysis of Connect Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Connect to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Connect Stock analysis

When running Connect Biopharma's price analysis, check to measure Connect Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Connect Biopharma is operating at the current time. Most of Connect Biopharma's value examination focuses on studying past and present price action to predict the probability of Connect Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Connect Biopharma's price. Additionally, you may evaluate how the addition of Connect Biopharma to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital